Jamie Haney is the General Counsel of the Lilly Diabetes organization at Eli Lilly. In her role, she provides counsel regarding various issues including healthcare regulation, FDA advertising and promotion laws, Lanham Act, and other general corporate matters. Jamie provides legal support to the company on general antitrust matters and is a member of the PhRMA Antitrust Focus Group. Jamie also serves a key leadership role on the Lilly Diabetes executive team and the Lilly General Counsel leadership team.
Previously, Jamie served as Assistant Secretary and corporate securities counsel for Lilly, where she worked closely with the Lilly Executive Committee and the Lilly Board of Directors, couseling on corporate governance, securities laws, general banking and commercial issues.
Before coming to Lilly, Jamie was an associate at Sidley Austin LLP in Chicago, Illinois in the Commercial Competition and Securities Litigation group, where she primarily worked on antitrust and class action securities cases. She is a graduate of DePaul University College of Law, and Purdue University.
Areas of Practice
Drug & Medical Device
Lilly Millennial Think Tank
DePaul University College of LawUpdate this Profile